GO:0042340 keratan sulfate proteoglycan catabolic process: Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042340 describes the biological process that breaks down keratan sulfate proteoglycans, extracellular matrix molecules made of a core protein and keratan sulfate glycosaminoglycan chains.
• Keratan sulfate chains are repeating disaccharides of beta-(1,4)-N-acetyl-D-glucosamine and beta-(1,3)-galactose, which can be sulfated, and their catabolism requires coordinated glycosidase and sulfatase activities.
• Defective keratan sulfate proteoglycan catabolism is linked to macular corneal dystrophy, a corneal clouding disorder caused by mutations affecting keratan sulfate sulfation.
• Keratan sulfate proteoglycans such as lumican, keratocan, and mimecan are major corneal stroma components, and their turnover is essential for corneal transparency.
• Keratan sulfate proteoglycan catabolism is also implicated in cortical injury responses, tumour microenvironments, and tooth development, making it relevant beyond the eye.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes involved in keratan sulfate proteoglycan catabolic process.
Description
Keratan sulfate proteoglycan catabolic process (GO:0042340) is the set of chemical reactions and pathways that result in the breakdown of keratan sulfate proteoglycans, which consist of a core protein linked to a keratan sulfate glycosaminoglycan. The keratan sulfate chain is composed of the repeating disaccharide unit beta-(1,4)-N-acetyl-D-glucosamine-beta-(1,3)-galactose, both of which can be sulfated. This process is a specialized branch of extracellular matrix turnover that controls the abundance and structure of keratan sulfate proteoglycans in tissues such as cornea, cartilage, brain, and tooth. Researchers study GO:0042340 because defects in keratan sulfate metabolism cause human disease, most notably macular corneal dystrophy, and because keratan sulfate proteoglycans modulate cell behaviour in injury, development, and cancer. Understanding the catabolic steps, the enzymes involved, and the regulatory inputs provides a framework for therapeutic and diagnostic strategies.
keratan sulfate proteoglycan catabolic process At A Glance
| GO ID | GO:0042340 |
|---|---|
| GO term | keratan sulfate proteoglycan catabolic process |
| Ontology | biological_process |
| Synonym | keratan sulfate breakdown; keratan sulfate catabolism; keratan sulfate degradation; keratan sulphate catabolic process; keratan sulphate catabolism |
| Major function | Enzymatic breakdown of keratan sulfate proteoglycans, including keratan sulfate glycosaminoglycan chains and core proteins |
| Substrate | Keratan sulfate proteoglycans composed of a core protein and keratan sulfate chains of repeating beta-(1,4)-N-acetyl-D-glucosamine-beta-(1,3)-galactose disaccharides |
| Key tissue contexts | Cornea, cartilage, brain, tooth, and tumour microenvironment |
| Related disease | Macular corneal dystrophy due to defective keratan sulfate sulfation and turnover |
| Research relevance | Target for extracellular matrix turnover studies, corneal disease models, and cancer matrix biology |
What Is GO:0042340?
In simple terms, GO:0042340 is the process that dismantles keratan sulfate proteoglycans. A keratan sulfate proteoglycan is a core protein decorated with keratan sulfate glycosaminoglycan chains, and catabolism means the stepwise enzymatic breakdown of those chains and the protein core. The keratan sulfate chain itself is a polymer of repeating disaccharide units, beta-(1,4)-N-acetyl-D-glucosamine-beta-(1,3)-galactose, with sulfate groups attached at various positions. The catabolic process therefore includes the removal of sulfate groups, cleavage of the glycosidic bonds between sugars, and degradation of the core protein, releasing free sugars, sulfate, and amino acids for recycling or further metabolism.
Why Is keratan sulfate proteoglycan catabolic process Important in Cell Biology?
GO:0042340 matters because keratan sulfate proteoglycan catabolism controls the composition and mechanical properties of extracellular matrices in the cornea, cartilage, brain, and other tissues. When this process is impaired, keratan sulfate proteoglycans accumulate or are abnormally modified, leading to corneal opacity in macular corneal dystrophy and contributing to altered matrix remodelling in injury and cancer. Studying the catabolic machinery also reveals how cells recycle glycosaminoglycans and how sulfation patterns influence protein interactions and signalling.
• Maintains corneal transparency by regulating keratan sulfate proteoglycan turnover in the stroma.
• Underlies macular corneal dystrophy, where defective keratan sulfate sulfation leads to corneal clouding.
• Modulates extracellular matrix remodelling after cortical injury in the brain.
• Influences tooth development through glycosaminoglycan turnover.
• Shapes the tumour microenvironment by controlling keratan sulfate proteoglycan availability.
• Provides a model for understanding glycosaminoglycan catabolism and lysosomal storage disorders.
• Enables identification of enzyme deficiencies through biochemical and genetic screens.
• Supports development of biomarkers for corneal and matrix-related diseases.
• Guides tissue-engineering strategies that require controlled matrix degradation.
• Offers targets for CRISPR-based functional studies of matrix turnover genes.
What Happens During keratan sulfate proteoglycan catabolic process?
Recognition and initial processing of keratan sulfate proteoglycans
In simple terms: The cell first identifies keratan sulfate proteoglycans that need to be broken down and begins to modify them.
Keratan sulfate proteoglycans are extracellular matrix molecules composed of a core protein and keratan sulfate glycosaminoglycan chains. Catabolism begins when these molecules are recognized and internalized or when extracellular proteases and glycosidases initiate cleavage. The core proteins, such as lumican, keratocan, and mimecan, are subject to proteolytic processing, while the keratan sulfate chains are exposed for glycosidase action. This step is important because it determines which proteoglycans are targeted for degradation and at what rate.
Desulfation of keratan sulfate chains
In simple terms: Sulfate groups are removed from the sugar chains so that the sugars can be cut apart.
Keratan sulfate chains contain sulfate groups on the N-acetyl-D-glucosamine and galactose residues. Sulfatases remove these sulfate groups, converting the chains into less charged intermediates that are accessible to glycosidases. Defects in sulfation or desulfation are linked to macular corneal dystrophy, where abnormal keratan sulfate sulfation leads to corneal opacity. This step is therefore critical for normal turnover and for preventing accumulation of undersulfated or oversulfated keratan sulfate.
Glycosidic cleavage of keratan sulfate disaccharides
In simple terms: Enzymes cut the sugar chain into smaller pieces by breaking the bonds between sugars.
The keratan sulfate chain is a polymer of repeating disaccharide units, beta-(1,4)-N-acetyl-D-glucosamine-beta-(1,3)-galactose. Glycosidases, including exoglycosidases and endoglycosidases, cleave the glycosidic bonds to release disaccharides and monosaccharides. These reactions are sequential and often occur in lysosomes or at the cell surface. The resulting sugars can be further degraded or recycled. This step is the core of GO:0042340 and determines the rate of keratan sulfate clearance.
Core protein degradation and amino acid recycling
In simple terms: After the sugar chains are removed, the protein part is broken down into amino acids.
Once the keratan sulfate chains are removed, the core protein is degraded by proteases. The core proteins of keratan sulfate proteoglycans include lumican, keratocan, and mimecan, which are known to be expressed in cornea and other tissues. Proteolysis releases amino acids that can be reused for protein synthesis. This step completes the catabolic process and ensures that no partially degraded proteoglycans accumulate. Dysregulation of core protein degradation can affect matrix organization and cell signalling.
Integration with extracellular matrix turnover and signalling
In simple terms: The breakdown products can send signals and influence how the matrix is rebuilt.
Keratan sulfate proteoglycan catabolism is not just a disposal pathway; the released fragments can act as signalling molecules or modulate growth factor activity. In the tumour microenvironment, keratan sulfate proteoglycans influence cell behaviour, and their catabolism may alter cancer cell invasion and immune interactions. In the brain, up-regulation of a keratan sulfate proteoglycan follows cortical injury, suggesting a role in repair. Thus, GO:0042340 is integrated with tissue remodelling and cell signalling.
Key Genes Involved in GO:0042340 keratan sulfate proteoglycan catabolic process
The following genes and proteins are experimentally implicated in keratan sulfate proteoglycan biology and catabolism, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LUM | Core protein of keratan sulfate proteoglycan lumican in cornea and other matrices | Corneal transparency and matrix assembly studies |
| KERA | Core protein keratocan, a keratan sulfate proteoglycan in cornea | Corneal dystrophy and development models |
| OGN | Core protein mimecan, a keratan sulfate proteoglycan | Matrix turnover and eye research |
| CHST6 | Carbohydrate sulfotransferase 6, required for keratan sulfate sulfation | Macular corneal dystrophy genetics |
| CHST1 | Carbohydrate sulfotransferase 1, involved in keratan sulfate sulfation | Glycosaminoglycan biosynthesis and catabolism |
| CHST2 | Carbohydrate sulfotransferase 2, contributes to keratan sulfate sulfation | Sulfation pattern studies |
| CHST4 | Carbohydrate sulfotransferase 4, involved in keratan sulfate modification | Enzyme specificity research |
| B3GNT2 | Beta-1,3-N-acetylglucosaminyltransferase, extends keratan sulfate chains | Glycosyltransferase function |
| B4GALT1 | Beta-1,4-galactosyltransferase, adds galactose to keratan sulfate | Chain elongation studies |
| GALNS | N-acetylgalactosamine-6-sulfatase, degrades keratan sulfate-related substrates | Lysosomal storage disease models |
| GLB1 | Beta-galactosidase, removes galactose from keratan sulfate chains | Glycosidase deficiency research |
| HEXB | Beta-hexosaminidase subunit beta, cleaves N-acetylglucosamine residues | Lysosomal catabolism studies |
| IDS | Iduronate-2-sulfatase, sulfatase involved in glycosaminoglycan degradation | Enzyme replacement research |
| SULF1 | Sulfatase 1, modifies sulfation of glycosaminoglycans | Sulfation editing studies |
| SULF2 | Sulfatase 2, modifies sulfation of glycosaminoglycans | Matrix signalling research |
| MMP2 | Matrix metalloproteinase 2, degrades core proteins of proteoglycans | Matrix remodelling models |
| MMP9 | Matrix metalloproteinase 9, degrades core proteins of proteoglycans | Inflammation and cancer studies |
How Is keratan sulfate proteoglycan catabolic process Regulated?
Keratan sulfate proteoglycan catabolic process is regulated at multiple levels. Sulfation of keratan sulfate chains, controlled by carbohydrate sulfotransferases such as CHST6, determines susceptibility to desulfation and glycosidase action. Expression of core proteins like lumican, keratocan, and mimecan changes during development and after injury, altering substrate availability. In the tumour microenvironment, keratan sulfate proteoglycan turnover is influenced by matrix metalloproteinases and sulfatases, which are themselves regulated by growth factors and inflammatory signals. Lysosomal pH and enzyme trafficking also control the rate of glycosaminoglycan degradation. Together, these layers ensure that keratan sulfate proteoglycan catabolism is tuned to tissue needs.
keratan sulfate proteoglycan catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHST6 | Macular corneal dystrophy due to defective keratan sulfate sulfation | Knockout or point-mutation in corneal cell lines |
| LUM | Corneal transparency and matrix organization | Knockout mouse or corneal organoid |
| KERA | Corneal dystrophy and development | Knock-in of patient variants |
| MMP2 | Matrix remodelling in cancer and injury | Overexpression in cancer cell lines |
| MMP9 | Inflammation and tumour invasion | Knockout in immune or cancer cells |
Macular corneal dystrophy
Macular corneal dystrophy is a corneal clouding disorder caused by mutations in CHST6, which encodes a carbohydrate sulfotransferase required for keratan sulfate sulfation. Defective sulfation leads to abnormal keratan sulfate proteoglycan metabolism and accumulation in the corneal stroma, resulting in opacity. This disease directly links GO:0042340 to human pathology and provides a model for studying keratan sulfate catabolism.
Cortical injury and neural repair
Following cortical injury in neonatal rats, a keratan sulfate proteoglycan is up-regulated, suggesting a role in the injury response and repair. Altered catabolism of keratan sulfate proteoglycans may influence axon guidance and glial scar formation. This highlights the importance of GO:0042340 beyond the eye.
Cancer and tumour microenvironment
Keratan sulfate in the tumour environment modulates cell behaviour and matrix properties. Catabolic enzymes that degrade keratan sulfate proteoglycans can affect cancer cell invasion, angiogenesis, and immune cell access. Therefore, GO:0042340 is relevant to cancer matrix biology and potential therapeutic targeting.
Tooth development
Glycosaminoglycans, including keratan sulfate, play significant roles in tooth development. Catabolism of keratan sulfate proteoglycans contributes to the dynamic remodelling of dental matrices. This extends the relevance of GO:0042340 to craniofacial biology.
From keratan sulfate proteoglycan catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CHST6 impair keratan sulfate catabolism? | CRISPR knockout of CHST6 in corneal epithelial cells |
| Does a specific point mutation in LUM alter proteoglycan turnover? | Point-mutation knock-in in HEK293 or corneal fibroblasts |
| Can tagged lumican track catabolic intermediates? | Knock-in of fluorescent or epitope tag at LUM locus |
| Does overexpression of MMP9 accelerate core protein degradation? | Overexpression of MMP9 in matrix-producing cells |
| Which glycosidases are required for keratan sulfate chain cleavage? | CRISPR library screening in glycosaminoglycan-accumulating cells |
| Does keratan sulfate catabolism affect tumour cell invasion? | Knockout of sulfatases in cancer cell lines followed by invasion assays |
How to Study the keratan sulfate proteoglycan catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic activity assay | Sulfatase and glycosidase activity | Enzyme deficiency screening |
| RNA-seq | Expression of keratan sulfate-related genes | Pathway analysis in disease models |
| Mass spectrometry glycomics | Keratan sulfate chain composition and sulfation | Structural characterization |
| Immunofluorescence | Localization of core proteins and keratan sulfate | Corneal tissue studies |
| CRISPR knockout screening | Genes required for keratan sulfate catabolism | Functional genomics |
| Western blot | Core protein levels and cleavage products | Proteolysis assessment |
| qPCR | mRNA levels of CHST6, LUM, KERA | Validation of transcriptomic changes |
| Organ culture | Matrix turnover in intact tissue | Corneal dystrophy modeling |
Biochemical assays for keratan sulfate catabolism
Keratan sulfate proteoglycan catabolism can be measured by quantifying keratan sulfate chains and core proteins using specific antibodies and glycosaminoglycan-binding probes. Enzymatic assays with synthetic substrates can determine sulfatase and glycosidase activities. These methods are foundational for studying GO:0042340.
Genomic and transcriptomic profiling
RNA-seq and single-cell transcriptomics can reveal expression changes in genes such as CHST6, LUM, KERA, and MMPs under conditions that alter keratan sulfate proteoglycan turnover. Comparing wild-type and mutant cells identifies pathways co-regulated with GO:0042340.
Proteomics and glycomics
Mass spectrometry-based proteomics and glycomics can characterize keratan sulfate proteoglycan core proteins and their glycosaminoglycan chains. These approaches detect sulfation patterns and degradation intermediates, providing direct evidence of catabolic activity.
Imaging of matrix turnover
Immunofluorescence and live-cell imaging with tagged core proteins or glycosaminoglycan probes can visualize keratan sulfate proteoglycan localization and degradation in real time. Corneal organ culture and tissue sections are common models.
How CRISPR Can Be Used to Study GO:0042340 keratan sulfate proteoglycan catabolic process
Knockout
CRISPR knockout of genes such as CHST6, LUM, or KERA can abolish keratan sulfate proteoglycan catabolism and reveal accumulation phenotypes. Knockout cell lines are useful for identifying which enzymes are essential for each step of GO:0042340.
Point Mutation
Point mutations that mimic patient variants, such as those in CHST6 associated with macular corneal dystrophy, can be introduced to study subtle effects on sulfation and catabolism. These models help distinguish loss-of-function from dominant-negative mechanisms.
Knock-in
Knock-in of tagged versions of core proteins like lumican allows tracking of keratan sulfate proteoglycan trafficking and degradation. Fluorescent or epitope tags enable live-cell imaging and biochemical pulldown.
Overexpression
Overexpression of catabolic enzymes such as MMP2 or MMP9 can accelerate core protein degradation and test whether increased catabolism alters matrix properties. Overexpression models are also used to study keratan sulfate chain-modifying enzymes.
How EDITGENE Supports keratan sulfate proteoglycan catabolic process Research
Researchers studying keratan sulfate proteoglycan catabolic process-related genes often need to determine whether a candidate gene is causally involved in matrix turnover, disease, or cell signalling. EDITGENE provides CRISPR-based cell models and screening services to enable these functional studies with high specificity and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for keratan sulfate proteoglycan catabolic process research.
Frequently Asked Questions About keratan sulfate proteoglycan catabolic process
What is keratan sulfate proteoglycan catabolic process?
It is the biological process (GO:0042340) that breaks down keratan sulfate proteoglycans, which are core proteins linked to keratan sulfate glycosaminoglycan chains.
What genes are involved in keratan sulfate proteoglycan catabolic process?
Genes include CHST6, LUM, KERA, OGN, and various sulfatases and glycosidases such as GALNS, GLB1, and HEXB.
What is the definition of GO:0042340?
GO:0042340 is defined as the chemical reactions and pathways resulting in the breakdown of keratan sulfate proteoglycans, whose keratan sulfate chains are repeating beta-(1,4)-N-acetyl-D-glucosamine-beta-(1,3)-galactose disaccharides that can be sulfated.
Which diseases are linked to keratan sulfate proteoglycan catabolism?
Macular corneal dystrophy is the best-characterized disease, caused by CHST6 mutations affecting keratan sulfate sulfation. It is also implicated in cortical injury and cancer matrix biology.
How is keratan sulfate proteoglycan catabolism studied?
Researchers use enzymatic assays, RNA-seq, proteomics, glycomics, imaging, and CRISPR screens to measure catabolic activity and identify regulators.
What is the role of CHST6 in keratan sulfate catabolism?
CHST6 encodes a sulfotransferase that sulfates keratan sulfate chains; its loss causes macular corneal dystrophy and abnormal proteoglycan turnover.
Can CRISPR be used to study keratan sulfate proteoglycan catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes involved in this process.
What are the main enzymes in keratan sulfate degradation?
Sulfatases remove sulfate groups, glycosidases cleave the sugar chains, and proteases degrade the core protein.
Why is keratan sulfate proteoglycan catabolism important for the cornea?
It maintains corneal transparency by controlling the turnover of keratan sulfate proteoglycans such as lumican and keratocan.
What model systems are used for keratan sulfate proteoglycan catabolic process research?
Corneal cell lines, organ cultures, knockout mice, and CRISPR-engineered human cells are commonly used.
Conclusion
GO:0042340, keratan sulfate proteoglycan catabolic process, is a specialized extracellular matrix turnover pathway with direct relevance to corneal disease, neural injury, cancer, and development. Its study requires integrating biochemical, genetic, and imaging approaches to dissect the stepwise degradation of keratan sulfate proteoglycans. CRISPR-based models from EDITGENE provide a robust platform for causal gene discovery and therapeutic target validation in this field.
References
- 1. Ricard-Blum S et al.. 2024. A biological guide to glycosaminoglycans: current perspectives and pending questions.. FEBS J 291(15):3331-3366 PMID: 38500384
- 2. Aggarwal S et al.. 2018. Macular corneal dystrophy: A review.. Surv Ophthalmol 63(5):609-617 PMID: 29604391
- 3. Funderburgh JL et al.. 1990. Isoforms of corneal keratan sulfate proteoglycan.. J Biol Chem 265(14):8297-303 PMID: 2139877
- 4. Geisert EE Jr et al.. 1996. Up-regulation of a keratan sulfate proteoglycan following cortical injury in neonatal rats.. Int J Dev Neurosci 14(3):257-67 PMID: 8842803
- 5. Melrose J. 2024. Keratan sulfate, an electrosensory neurosentient bioresponsive cell instructive glycosaminoglycan.. Glycobiology 34(3) PMID: 38376199
- 6. Inubushi T et al.. 2024. The significant role of glycosaminoglycans in tooth development.. Glycobiology 34(5) PMID: 38438145
- 7. Funderburgh JL et al.. 1986. Keratan sulfate proteoglycan during embryonic development of the chicken cornea.. Dev Biol 116(2):267-77 PMID: 2942429
- 8. Hayes AJ et al.. 2020. Keratan Sulphate in the Tumour Environment.. Adv Exp Med Biol 1245:39-66 PMID: 32266652
